Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Urgent Reduction of Intraocular Pressure With Ophthalmic Timolol Improve Recovery From Non-arteritic Anterior Ischemic Optic Neuropathy (NAION): a Randomized Study.

NCT01607671 is registered in ClinicalTrials.gov with Fraser Health as lead sponsor.

NCT NCT01607671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Urgent Reduction of Intraocular Pressure With Ophthalmic Timolol Improve Recovery From Non-arteritic Anterior Ischemic Optic Neuropathy (NAION): a Randomized Study.
Lead sponsor
Fraser Health
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2012
Completion date
November 30, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior ischemic optic neuropathy, ischemic optic neuropathy, optic neuropathy, anterior ischemic, optic neuropathy, ischemic